Press Releases

Mar 29, 2026

Hana Yamamoto

Press Releases

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Nanobiotix announced the presentation of early Phase 2 clinical trial results from the Johnson & Johnson-sponsored CONVERGE study evaluating the novel nanoradioenhancer JNJ-1900 (NBTXR3) in patients with stage 3 inoperable non-small cell lung cancer. Initial data demonstrate a favorable safety profile and encouraging efficacy signals, including a h…

NBTX

Mar 29, 2026

Sofia Navarro

Press Releases

Uniti Fiber Names Heather Orrico to Lead Enterprise Sales

Uniti Fiber announced the hiring of Heather Orrico as president of Enterprise Sales to enhance its enterprise sales strategy and drive growth in the Southeastern United States. With over 20 years of telecom experience and proven leadership at Comcast, Orrico's expertise is expected to strengthen Uniti Fiber's position in delivering fiber infrastruc…

UNIT

Mar 29, 2026

Hana Yamamoto

Press Releases

BiomX Adds Former Mossad Deputy to Advisory Board

BiomX Inc. appointed Dr. Ehud Levi, former Deputy Director of Mossad, to its Advisory Board to support strategic expansion into security, defense, aerial response, and counter-UAS technologies. Dr. Levi's extensive intelligence and counter-terrorism experience is expected to guide BiomX in exploring new partnerships and business opportunities in de…

PHGE

Mar 29, 2026

Marcus Reed

Press Releases

AleAnna, Inc. Reports Fourth Quarter and Full Year 2025 Results

AleAnna, Inc. announced its financial and operational results for Q4 and full year 2025, reporting a net income of $2.9 million and adjusted EBITDA of $6.6 million for the year. The company achieved strong production performance at its Longanesi field, which exceeded expectations and generated $9.1 million in revenue in Q4. AleAnna also secured the…

ANNA

Mar 29, 2026

Jordan Park

Press Releases

Siebert Reports 2025 Financial Results

Siebert Financial Corp. announced its 2025 financial results, showing a 12% revenue increase driven by a 51% rise in stock loan revenue and growth in retail customer net worth. However, operating income declined due to significant investments in new business lines and technology. The company expanded into collegiate athlete NIL negotiation services…

SIEB

Mar 29, 2026

Marcus Reed

Press Releases

AirJoule Technologies Announces Fourth Quarter and Full Year 2025 Results and Provides Business Update

AirJoule Technologies Corporation announced its Q4 and full year 2025 results, highlighting successful technology validation, product development, strategic partnerships with industry leaders and defense, and strengthened financial position. The company confirmed progress in field deployments across multiple geographies and outlined plans to launch…

AIRJ

Mar 29, 2026

Sofia Navarro

Press Releases

Allbirds Signs Definitive Asset Purchase Agreement with American Exchange Group

Allbirds, Inc. announced a definitive agreement to sell its intellectual property and certain assets to American Exchange Group for approximately $39 million. The sale, pending stockholder approval, will lead to the company's dissolution and winding down, with expected closure in Q2 2026 and distribution of net proceeds to shareholders in Q3 2026. …

BIRD

Mar 29, 2026

Derek Hwang

Press Releases

Caliber Announces Conversion of $15.9 Million of Preferred Equity into Common Stock

Caliber announced that an institutional investor converted $15.9 million of perpetual convertible preferred equity into common stock, reducing senior capital and simplifying its capital structure. This transaction enhances the company's financial flexibility and aligns interests with common shareholders. Caliber is a Nasdaq-listed real estate and d…

CWD

Mar 29, 2026

Ajmal Hussain

Press Releases

Intercont (Cayman) Limited Announces Effective Time of Share Consolidation/Reverse Share Split to Regain NASDAQ Compliance

Intercont (Cayman) Limited will implement a 25-for-1 reverse share split effective April 2, 2026 to comply with Nasdaq's minimum $1.00 bid price requirement. The company aims to maintain its listing on the Nasdaq Capital Market under ticker symbol NCT, with adjusted shares and a new CUSIP number. The reverse split reduces total authorized shares, a…

NCT

Mar 29, 2026

Caleb Monroe

Press Releases

JD.com Announces Proposed Offering of CNY-denominated Senior Notes

JD.com, Inc., a leading supply chain-based technology and service provider, announced its plan to offer CNY-denominated senior unsecured notes in offshore transactions targeting non-U.S. persons. The proceeds from this offering will be used for general corporate purposes including repayment of existing indebtedness. The notes offering is subject to…

JD

Mar 29, 2026

Derek Hwang

Press Releases

StoneX Payments Partners with The Pathfinder Group, Expanding Cross-Border Payment Capabilities

StoneX Group Inc. has formed a strategic partnership with The Pathfinder Group to integrate StoneX's institutional-grade cross-border payment infrastructure with Pathfinder's WITS™ platform. This collaboration aims to provide financial institutions, including community banks and credit unions, with access to improved global payment capabilities, be…

SNEX

Mar 29, 2026

Maya Rios

Press Releases

Iperionx – Change of Directors and Officers Ownership

IperionX Limited has reported recent changes in the ownership stakes of its directors and officers, filing the information with both the U.S. Securities and Exchange Commission and the Australian Securities Exchange. Key executives, including the CEO and President, have acquired additional shares and American Depositary Shares, reflecting internal …

IPX

Mar 29, 2026

Leila Farooq

Press Releases

BOSS Zhipin Surpasses RMB540 Million in Share Repurchases in 2026

KANZHUN LIMITED, known as BOSS Zhipin, announced it has repurchased over RMB540 million worth of shares so far in 2026, including a recent purchase of RMB34.5 million on March 27. This substantial share repurchase program highlights the company's commitment to enhancing shareholder value.

BZ

Mar 29, 2026

Caleb Monroe

Press Releases

Autozi Internet Technology (Global) Ltd. Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities

Autozi Internet Technology (Global) Ltd. announced that it received a notification from Nasdaq for failing to meet the minimum Market Value of Listed Securities of $50 million over the past 30 consecutive business days. The company has until September 21, 2026, to regain compliance or face potential delisting. The notification does not impact curre…

AZI

Mar 28, 2026

Caleb Monroe

Press Releases

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

MoonLake Immunotherapeutics reported Week 40 results from its Phase 3 VELA clinical trials evaluating sonelokimab in adults with moderate-to-severe hidradenitis suppurativa (HS). The data demonstrated continued improvement with 62% of patients achieving HiSCR75 and up to 32% achieving HiSCR100 responses, alongside significant quality of life enhanc…

MLTX

Mar 28, 2026

Avery Klein

Press Releases

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Kymera Therapeutics announced positive results from its BroADen Phase 1b trial of KT-621, a novel oral STAT6 degrader, in patients with moderate-to-severe atopic dermatitis. The data showed significant biological and clinical improvements with a favorable safety profile. Ongoing Phase 2b trials in atopic dermatitis and asthma are expected to provid…

KYMR

Mar 28, 2026

Derek Hwang

Press Releases

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Arcutis Biotherapeutics announced new positive Phase 2 results from the INTEGUMENT-INFANT trial showing that ZORYVE (roflumilast) cream 0.05% is effective and well tolerated in infants aged 3 months to less than 24 months with mild to moderate atopic dermatitis. Caregivers reported rapid itch improvement and multiple clinical endpoints demonstrated…

ARQT

Mar 27, 2026

Ajmal Hussain

Press Releases

Osisko Development Reports Fourth Quarter and Year-End 2025 Results

Osisko Development Corp. announced its financial and operational results for Q4 and full-year 2025, highlighting approximately CAD 422.3 million in cash, sales of nearly 4,000 ounces of gold from small-scale activities at the Tintic Project, and significant advancement in the Cariboo Gold Project's infill drilling and pre-construction activities. T…

ODV

Mar 27, 2026

Ajmal Hussain

Press Releases

Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency

Rocket Lab successfully launched its 85th mission, marking the first dedicated launch for the European Space Agency (ESA) using its Electron launch vehicle. The 'Daughter Of The Stars' mission delivered ESA's Celeste satellites to low Earth orbit to demonstrate enhanced satellite navigation alongside Europe's Galileo constellation. This success und…

RKLB

Mar 27, 2026

Sofia Navarro

Press Releases

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Alumis Inc. reported positive Phase 3 results for envudeucitinib, its oral TYK2 inhibitor, demonstrating robust skin clearance, rapid improvements in quality of life and itch relief, and a favorable safety profile in patients with moderate-to-severe plaque psoriasis. Data from two pivotal trials ONWARD1 and ONWARD2 indicate sustained efficacy throu…

ALMS

Mar 27, 2026

Hana Yamamoto

Press Releases

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

Priovant Therapeutics, a Roivant company, reported positive Phase 3 trial results for brepocitinib in dermatomyositis, showing statistically significant improvements over placebo in multiple efficacy endpoints including muscle strength, skin disease, physical function, and corticosteroid reduction. Results were published in the New England Journal …

ROIV

Mar 27, 2026

Caleb Monroe

Press Releases

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

Biogen announced positive Phase 2 results from the AMETHYST study for litifilimab, an investigational monoclonal antibody targeting BDCA2, demonstrating statistically significant improvement in skin disease activity in patients with cutaneous lupus erythematosus (CLE). These consistent positive results, along with a favorable safety profile and FDA…

BIIB

Mar 27, 2026

Derek Hwang

Press Releases

Fusion Fuel Highlights Royal Uranium’s 2% NSR on Two Mineral Claims held by the Shea Creek Joint Venture, One of Canada’s Largest Undeveloped Uranium Projects in the Athabasca Basin

Fusion Fuel Green PLC announced details on its anticipated 2% Net Smelter Return (NSR) royalty on two mineral claims within the Shea Creek Joint Venture, part of a 16-uranium-royalty portfolio expected to be acquired through its pending transaction with Royal Uranium Inc. The Shea Creek project hosts significant undeveloped uranium resources in Can…

HTOO

Mar 27, 2026

Priya Menon

Press Releases

Case IH Celebrates American Farmers At The White House

CNH Industrial's Case IH brand showcased its iconic Heartland Magnum tractor on the White House South Lawn during a presidential event celebrating American agriculture. This one-of-a-kind patriotic tractor symbolizes nearly four decades of manufacturing excellence and CNH's strong commitment to US farming and innovation. CNH Industrial, with a larg…

CNH

Mar 27, 2026

Marcus Reed

Press Releases

Magna Posts 2025 Annual Report

Magna International Inc., a leading global automotive supplier, has published its 2025 Annual Report, including financial statements and management analysis. The company announced its 2026 Annual Meeting of shareholders will be held virtually on May 4, 2026. Magna's reports are accessible on their website and regulatory agencies in Canada and the U…

MGA